Abstract:The last decade has witnessed the growing development of optical imaging using near-infrared (NIR) light (wavelength range: 700–1700 nm) in a wide range of applications, from fundamental research of live biological and physiological processes to clinical applications such as disease screening and image-guide surgical interventions. The low-energy NIR light offers reduced tissue scattering, absorption as well as autofluorescence background compared to traditional wavelengths in the visible (400–700 nm) range, thus dramatically enhancing imaging resolution, signal-to-noise ratio, and penetration depth. This Research Topic calls for advances in new fluorescent probes, imaging instrumentation, analytical methods and their applications for improvement of diagnosis and therapy in this “tissue transparent window,” aiming to provide a timely update of this continuously evolving filed. Imaging and diagnosis agents are the cornerstone of preclinical applications. In their study, Tan et al. report lycosin-I peptide modified gold nanoclusters (LGNCs), which exhibit strong NIR fluorescence, for imaging of specific cancer cell nuclei. The lycosin-I peptide not only possesses highly efficient and selective intracellular translocation against several cancer cells, but also induces aggregation of gold nanoclusters to further enhance their brightness. After uptake by tumor cells, the LGNCs aggregates can be depolymerized into ultrasmall nanoclusters by the high level GSH in the tumor microenvironment, facilitating nuclear targeting translocation in cancer cells. Another study by Huang et al. reports a novel biomimetic nanoprobe for photoacoustic (PA) imaging of cervical carcinoma. This probe is constructed by coating indocyanine green (ICG)-loaded mesoporous silica nanoparticles with the cancer cell membrane, providing small particle size, excellent dispersion, large loading efficiency, good biocompatibility and homologous targeting ability to Hela cells in vitro. The biomimetic nanoprobe can specifically accumulate into tumor and display a superior PA imaging efficacy compared with free ICG, allowing for non-invasive deep tissue imaging of cervical carcinoma in vivo. Another article by Gu et al. focuses on a particular type of NIR fluorophores, semiconducting polymer nanoparticles (SPNs). SPNs are constructed by encapsulating hydrophobic semiconducting polymers (SPs) with amphiphilic copolymers, and have shown great promise for phototheranostics of cancer. The authors review recent advances of thiadiazoloquinoxaline (TQ)-based SPNs from their synthesis and hydrophilic functionalization to NIR-II (1,000–1,700 nm) fluorescence imagingguided cancer photothermal therapy (PTT). To enhance the PTT efficiency, they also discuss methods for constructing SPNs with capability of multimodal imaging. Current limitations are summarized at the end that hamper clinical applications of the SPNs, such as relatively large size and low tumor targeting ability. Edited and reviewed by: Gianni Ciofani, Italian Institute of Technology (IIT), Italy

Photosensitizer Encapsulated Organically Modified Silica Nanoparticles for Direct Two-Photon Photodynamic Therapy and in Vivo Functional Imaging

Photosensitizer Encapsulated Organically Modified Silica (ORMOSIL) Nanoparticles for Tumor Diagnosis and Photodynamic Therapy

Fluorescent AIE Dots Encapsulated Organically Modified Silica (ORMOSIL) Nanoparticles for Two-Photon Cellular Imaging

Organic Nanoparticles with Persistent Luminescence for in Vivo Afterglow Imaging-Guided Photodynamic Therapy

Photosensitizer Doped Colloidal Mesoporous Silica Nanoparticles for Three-Photon Photodynamic Therapy

Bio-molecule-conjugated fluorescent organically modified silica nanoparticles as optical probes for cancer cell imaging.

Boron Dipyrromethene-Based Phototheranostics for Near Infrared Fluorescent and Photoacoustic Imaging-Guided Synchronous Photodynamic and Photothermal Therapy of Cancer

BODIPY-doped Silica Nanoparticles with Reduced Dye Leakage and Enhanced Singlet Oxygen Generation.

Stable Organic Photosensitizer Nanoparticles with Absorption Peak beyond 800 Nanometers and High Reactive Oxygen Species Yield for Multimodality Phototheranostics

Organic Semiconducting Macromolecular Dyes for NIR‐II Photoacoustic Imaging and Photothermal Therapy

Reversible pH-switchable NIR-II nano-photosensitizer for precise imaging and photodynamic therapy of tumors

Organic semiconducting polymer amphiphile for near-infrared-II light-triggered phototheranostics

Organically modified silica nanoparticles with photosensitizing drugs encapsulated for photodynamic therapy

Smart On-Site Immobilizable Near-Infrared II Fluorescent Nanoprobes for Ultra-Long-Term Imaging-Guided Tumor Surgery and Photothermal Therapy

Photosensitizer-Singlet Oxygen Sensor Conjugated Silica Nanoparticles for Photodynamic Therapy and Bioimaging

Peptide-based semiconducting polymer nanoparticles for osteosarcoma-targeted NIR-II fluorescence/NIR-I photoacoustic dual-model imaging and photothermal/photodynamic therapies

Colloidal mesoporous silica nanoparticles with protoporphyrin IX encapsulated for photodynamic therapy.

Editorial: Precise Diagnosis and Therapy Using Near-Infrared Light

Intraparticle Molecular Orbital Engineering of Semiconducting Polymer Nanoparticles As Amplified Theranostics for in Vivo Photoacoustic Imaging and Photothermal Therapy.

Iodine-Rich Semiconducting Polymer Nanoparticles for CT/Fluorescence Dual-Modal Imaging-Guided Enhanced Photodynamic Therapy

1064 nm activatable semiconducting polymer-based nanoplatform for NIR-II fluorescence/NIR-II photoacoustic imaging guided photothermal therapy of orthotopic osteosarcoma